Clinical and Laboratory Characteristics of Patients Admitted With Syncope; Diagnosis and Follow up After These Patients
The investigators hypothesis is that a significant number of patients may remain without specific cause and have recurrent syncope with its associated physical and mental morbidity.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Observational Study Following After Patients Admitted With Syncope|
- diagnosis [ Time Frame: 1 year ] [ Designated as safety issue: No ]Final diagnosis as a cause of syncope
- recurrence [ Time Frame: 6 months ] [ Designated as safety issue: No ]how many patients had recurrence of syncope and average number of syncope in these patients during the period of follow up of each patient.
- physical injury [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]During this period of follow up of each patient, was there a physical injury, graded either none, mild, moderate or severe (bedridden)
- Mental effect [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]fear of recurrent syncope affecting his mobility and graded from mild to severe where severe indicates fear of moving even one step without support.
|Study Start Date:||August 2010|
|Estimated Study Completion Date:||June 2011|
- Patients with diagnosis of syncope who were admitted to the medical ward will be interviewed and their charts reviewed to rule in or out the diagnosis of syncope.
- Assess physical and mental injury as a result of syncope.
The lab workup will be documented including;
- Routine blood tests.
- troponin level.
- Brain CT.
- U/S doppler of carotids.
- Tilt tests.
- At the time of diagnosis the final diagnosis will be documented including recommendations for patients to prevent syncope after discharge.
- Follow up after patients by phone verifying recurrence of syncope and resulting physical and or mental injury if any.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01201993
|Department of Medicine, Carmel Medical Center|
|Haifa, Israel, 34362|
|Principal Investigator:||George S Habib, M.D.||Carmel Medical Center|